Tarus Therapeutics | 160 followers on LinkedIn. Tarus is developing highly potent and selective antagonists for A2A and A2B receptors for the treatment of cancer. | Tarus Therapeutics is a biotechnology company focused on nucleotide metabolism in cancer. The company’s lead programs target the immunosuppressive adenosine pathway in the tumor microenvironment (TME) for the treatment of resistant cancers. Adenosine is recognized as a key metabolic checkpoint, and high levels of extracellular adenosine have been evidenced to mediate profound tumor resistance.
View Top Employees from Tarus Therapeutics| Website | https://tarustx.com |
| Employees | 9 (3 on RocketReach) |
| Founded | 2019 |
| Technologies |
JavaScript,
HTML,
PHP
+10 more
(view full list)
|
| Industry | Biotechnology, Other Healthcare Services |
Looking for a particular Tarus Therapeutics employee's phone or email?
Tarus Therapeutics Questions
Peter Molloy is the Founder and Executive Director of Tarus Therapeutics.
3 people are employed at Tarus Therapeutics.
Tarus Therapeutics is based in New York, New York.
Top Tarus Therapeutics Employees
-
55
-
ViewPeter Molloy
Founder and Executive Director at Tarus Therapeutics
New York, New York, United States32 -
View
Sushant Kumar
Founder, President and Chief Executive Officer at Tarus Therapeutics
New York, New York, United States45
Related Companies
